NCT00441025View on ClinicalTrials.gov

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

August 31, 2009

Conditions
Peripheral T-Cell Lymphoma
Interventions
DRUG

Alemtuzumab

Trial Locations (1)

10700

Siriraj Hospital, Mahidol University, Bangkoknoi

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Mahidol University

OTHER